Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Collaborative Program to Accelerate Therapeutics Development for Spinal Muscular Atrophy (SMA)
Release Date: April 10, 2003
Announcement Number: NOT-NS-03-012
Funding Contact: NINDS Funding
Program Area: Office of Translational Research, Contracts Management Branch
Also See:
http://www.ninds.nih.gov/funding/funding_announcements/RFP_SMA_04_2003.pdf
Brief Description:
NINDS' research goal for Spinal Muscular Atrophy is to efficiently translate a mechanistic understanding of SMA into a testable
therapy suitable for clinical trials. The NINDS strategy for achieving its research goal is to fund parallel therapeutic pathways
in a rapid milestone-driven process that will identify a promising therapeutic candidate. This project will require a high
level of scientific expertise and experience on the part of the contractor. Furthermore, efficient progress will involve an
unusual degree of acceleration and integration of multiple research projects, and thus success will also require that the
contractor use creativity and flexibility in applying that scientific expertise.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |